|  | Follow-up time | ||
---|---|---|---|---|
Study variable | Groups | T1–T0 | T2–T0 | T3–T0 |
VAS max | CT | 3.63 ± 1.39 | 4.69 ± 1.28 | 5.78 ± 1.56 |
PT | 3.16 ± 1.53 | 4.38 ± 1.81 | 5.31 ± 2.05 | |
P-value | 0.347b | 0.460b | 0.429b | |
VAS resting | CT | 1.78 ± 1.66 | 2.13 ± 1.96 | 2.59 ± 2.21 |
PT | 1.13 ± 1.60 | 1.47 ± 1.88 | 1.56 ± 1.92 | |
P-value | 0.084b | 0134b | 0.051b | |
VAS opening | CT | 2.97 ± 2.09 | 4.06 ± 2.26 | 4.94 ± 2.05 |
PT | 1.78 ± 1.96 | 2.75 ± 2.37 | 3.50 ± 2.58 | |
P-value | 0.018b,* | 0.045b,* | 0.032b,* | |
VAS chewing | CT | 2.88 ± 1.83 | 3.97 ± 1.84 | 4.91 ± 1.65 |
PT | 2.59 ± 1.74 | 3.91 ± 2.31 | 4.56 ± 2.31 | |
P-value | 0.544b | 0.753b | 0.541b | |
MMO (mm) | CT | 5.13 ± 4.23 | 7.78 ± 5.18 | 10.09 ± 5.74 |
PT | 6.81 ± 3.78 | 9.88 ± 4.47 | 11.50 ± 5.34 | |
P-value | 0.034b,* | 0.056b | 0.309b | |
TMJ crepitus | CT | 2/32 | 6/32 | 9/32 |
PT | 4/32 | 6/32 | 7/32 | |
P-value | 0.581c | 0.885c | 0.357c | |
JFLS score | CT | 17.47 ± 8.77 | 23.28 ± 9.96 | 27.53 ± 9.92 |
PT | 15.41 ± 9.93 | 20.81 ± 10.59 | 27.44 ± 12.16 | |
P-value | 0.382a | 0.364a | 0.973a |